A
bstract
We show that vector-like fermions can act as the dark matter candidate in the universe whilst also playing a crucial role in electroweak baryogenesis through contributing to the barrier in ...the one-loop thermal scalar potential. In order for the new fermions to give rise to a strong first order phase transition, we show that one requires rather large Yukawa couplings in the new sector, which are strongly constrained by electroweak precision tests and perturbativity. Strong couplings between the dark matter candidate and the Higgs boson intuitively lead to small values of the relic density and problems with dark matter direct detection bounds. Nevertheless, when considering the most general realisation of the model, we find regions in the parameter space that respect all current constraints and may explain both mysteries simultaneously.
Strain-hardening cement-based composites were named after their ability to resist increased tensile force after crack formation, over a significant tensile deformation range. The increased resistance ...is achieved through effective crack bridging by fibres, across multiple cracks of widths in the micro-range. Whether these small crack widths are maintained under sustained, cyclic or other load paths, and whether the crack width limitation translates into durability through retardation of moisture, gas and other deleterious matter ingress, are scrutinised in this paper by evaluation of test results from several laboratories internationally. This contribution is a short version of the State-of-the-Art report by RILEM TC 208-HFC, Subcommittee 2: Durability, developed during the committee life 2005–2009.
This paper presents original findings on the heterogeneity of the mechanical properties of concrete of an early age, dependent on the evolution of the hydration reaction. The properties investigated ...are the compressive strength, the Young’s modulus, and the flexural tensile strength. To achieve this, we employed a testing apparatus in which the samples underwent curing in a chamber that followed the same temperature profile as an adiabatic calorimeter. This method enabled us to monitor the hydration progress across multiple samples. We used a function derived from the literature, with specific adaptations, to model the evolution of normalized properties in relation to hydration. Heterogeneity was quantified through the use of the dispersion coefficient. The key finding of this study is that the dispersion coefficient for the analyzed mechanical properties diminishes with the advancement of hydration, until reaching a specific threshold. Beyond this point, the impact of microcracking on the various properties becomes increasingly pronounced, varying according to the particular property being examined. Moreover, this paper presents initial functions designed to offer formulas that assist in modeling concrete within probabilistic numerical simulations from the early stages of its development.
The Brazilian ceramic industry generates large amounts of calcined-clay waste. This paper examines the factors that influence its potential for use as a partial replacement of Portland cement. ...Superplasticized mortars of equal workability containing ground crushed waste calcined-clay brick (GCWCCB) in the proportions of 10, 20, 30 and 40% as a cement replacement were analyzed through mechanical tests, pore structure characterization and durability tests. The results indicated the optimal percentages of substitution lies between 10% to 20%. The potential reduction of CO
2 emissions could be as high as 10% of current Brazilian cement industry emissions if this approach were to be fully implemented, and it could be eligible for “Clean Development Mechanism” credits under Kyoto protocol.
Post-COVID-19 condition (also known as long COVID) is an emerging chronic illness potentially affecting millions of people. We aimed to evaluate whether outpatient COVID-19 treatment with metformin, ...ivermectin, or fluvoxamine soon after SARS-CoV-2 infection could reduce the risk of long COVID.
We conducted a decentralised, randomised, quadruple-blind, parallel-group, phase 3 trial (COVID-OUT) at six sites in the USA. We included adults aged 30–85 years with overweight or obesity who had COVID-19 symptoms for fewer than 7 days and a documented SARS-CoV-2 positive PCR or antigen test within 3 days before enrolment. Participants were randomly assigned via 2 × 3 parallel factorial randomisation (1:1:1:1:1:1) to receive metformin plus ivermectin, metformin plus fluvoxamine, metformin plus placebo, ivermectin plus placebo, fluvoxamine plus placebo, or placebo plus placebo. Participants, investigators, care providers, and outcomes assessors were masked to study group assignment. The primary outcome was severe COVID-19 by day 14, and those data have been published previously. Because the trial was delivered remotely nationwide, the a priori primary sample was a modified intention-to-treat sample, meaning that participants who did not receive any dose of study treatment were excluded. Long COVID diagnosis by a medical provider was a prespecified, long-term secondary outcome. This trial is complete and is registered with ClinicalTrials.gov, NCT04510194.
Between Dec 30, 2020, and Jan 28, 2022, 6602 people were assessed for eligibility and 1431 were enrolled and randomly assigned. Of 1323 participants who received a dose of study treatment and were included in the modified intention-to-treat population, 1126 consented for long-term follow-up and completed at least one survey after the assessment for long COVID at day 180 (564 received metformin and 562 received matched placebo; a subset of participants in the metformin vs placebo trial were also randomly assigned to receive ivermectin or fluvoxamine). 1074 (95%) of 1126 participants completed at least 9 months of follow-up. 632 (56·1%) of 1126 participants were female and 494 (43·9%) were male; 44 (7·0%) of 632 women were pregnant. The median age was 45 years (IQR 37–54) and median BMI was 29·8 kg/m2 (IQR 27·0–34·2). Overall, 93 (8·3%) of 1126 participants reported receipt of a long COVID diagnosis by day 300. The cumulative incidence of long COVID by day 300 was 6·3% (95% CI 4·2–8·2) in participants who received metformin and 10·4% (7·8–12·9) in those who received identical metformin placebo (hazard ratio HR 0·59, 95% CI 0·39–0·89; p=0·012). The metformin beneficial effect was consistent across prespecified subgroups. When metformin was started within 3 days of symptom onset, the HR was 0·37 (95% CI 0·15–0·95). There was no effect on cumulative incidence of long COVID with ivermectin (HR 0·99, 95% CI 0·59–1·64) or fluvoxamine (1·36, 0·78–2·34) compared with placebo.
Outpatient treatment with metformin reduced long COVID incidence by about 41%, with an absolute reduction of 4·1%, compared with placebo. Metformin has clinical benefits when used as outpatient treatment for COVID-19 and is globally available, low-cost, and safe.
Parsemus Foundation; Rainwater Charitable Foundation; Fast Grants; UnitedHealth Group Foundation; National Institute of Diabetes, Digestive and Kidney Diseases; National Institutes of Health; and National Center for Advancing Translational Sciences.
This paper presents a study of cement replacement by sugar cane bagasse ash (SCBA) in industrial scale aiming to reduce the CO2 emissions into the atmosphere. SCBA is a by-product of the ...sugar/ethanol agro-industry abundantly available in some regions of the world and has cementitious properties indicating that it can be used together with cement. Recent comprehensive research developed at the Federal University of Rio de Janeiro/Brazil has demonstrated that SCBA maintains, or even improves, the mechanical and durability properties of cement-based materials such as mortars and concretes. Brazil is the world’s largest sugar cane producer and being a developing country can claim carbon credits. A simulation was carried out to estimate the potential of CO2 emission reductions and the viability to issue certified emission reduction (CER) credits. The simulation was developed within the framework of the methodology established by the United Nations Framework Convention on Climate Change (UNFCCC) for the Clean Development Mechanism (CDM). The State of São Paulo (Brazil) was chosen for this case study because it concentrates about 60% of the national sugar cane and ash production together with an important concentration of cement factories. Since one of the key variables to estimate the CO2 emissions is the average distance between sugar cane/ethanol factories and the cement plants, a genetic algorithm was developed to solve this optimization problem. The results indicated that SCBA blended cement reduces CO2 emissions, which qualifies this product for CDM projects.
PDF
